Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to 0.37.

  • Traws Pharma's Equity Ratio rose 26055.16% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year increase of 26055.16%. This contributed to the annual value of 1.27 for FY2024, which is 36932.36% down from last year.
  • Per Traws Pharma's latest filing, its Equity Ratio stood at 0.37 for Q3 2025, which was up 26055.16% from 0.53 recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Equity Ratio registered a high of 0.83 during Q4 2021, and its lowest value of 5.65 during Q2 2024.
  • For the 5-year period, Traws Pharma's Equity Ratio averaged around 0.16, with its median value being 0.62 (2023).
  • Per our database at Business Quant, Traws Pharma's Equity Ratio plummeted by 101043.0% in 2024 and then surged by 26055.16% in 2025.
  • Quarter analysis of 5 years shows Traws Pharma's Equity Ratio stood at 0.83 in 2021, then dropped by 13.51% to 0.72 in 2022, then plummeted by 34.57% to 0.47 in 2023, then tumbled by 369.32% to 1.27 in 2024, then soared by 128.83% to 0.37 in 2025.
  • Its Equity Ratio stands at 0.37 for Q3 2025, versus 0.53 for Q2 2025 and 0.31 for Q1 2025.